-
Expectant Management or Early Ibuprofen for Patent Ductus Arteriosus.
Hundscheid, T., Onland, W., Kooi, E. M. W., Vijlbrief, D. C., de Vries, W. B., Dijkman, K. P., van Kaam, A. H., Villamor, E., Kroon, A. A., Visser, R., Mulder-de Tollenaer, S. M., de Bisschop, B., Dijk, P. H., Avino, D., Hocq, C., Zecic, A., Meeus, M., de Baat, T., Derriks, F., Henriksen, T. B., & 7 others , 2023, In: The New England journal of medicine. 388, 11, p. 980-990 11 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Clinical predictors of bacteraemia in neonates with suspected early-onset sepsis in Malawi: A prospective cohort study
de Baat, T., Lester, R., Ghambi, L., Twabi, H. H., Nielsen, M., Gordon, S. B., van Weissenbruch, M. M., Feasey, N. A., Dube, Q., Kawaza, K. & Iroh Tam, P-Y., 2022, (E-pub ahead of print) In: Archives of disease in childhood. 324476.Research output: Contribution to journal › Article › Academic › peer-review
-
Multi-centre, randomised non-inferiority trial of early treatment versus expectant management of patent ductus arteriosus in preterm infants (the BeNeDuctus trial): statistical analysis plan
on behalf of the BeNeDuctus trial study group, 1 Dec 2021, In: Trials. 22, 1, 627.Research output: Contribution to journal › Article › Academic › peer-review
- All publications